通化东宝：关于门冬胰岛素注射液获得境外药品注册证书的公告

Core Viewpoint - Tonghua Dongbao has received the drug registration certificate for insulin aspart injection from the Indonesian Food and Drug Authority, indicating a significant regulatory approval for the company’s product in the Indonesian market [1] Group 1 - The company announced the receipt of the drug registration certificate on October 24 [1] - The registration number for the insulin aspart injection is DKI2570600143A1 [1]